Back
Unicycive Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
UNCY
Unicycive Therapeutics, Inc.
Last Price:
$5.57
Seasonality Move:
72.91%
7 Day Trial
ALL ACCESS PASS
$
7
Unicycive Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Unicycive Therapeutics, Inc. has on average historically fallen by 21.6% based on the past 4 years of stock performance.
-
Unicycive Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Unicycive Therapeutics, Inc. Stock Undervalued?The current Unicycive Therapeutics, Inc. [UNCY] share price is $5.56. The Score for UNCY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
UNCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Unicycive Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Unicycive Therapeutics, Inc. has on average historically fallen by 21.6% based on the past 4 years of stock performance.
Unicycive Therapeutics, Inc. Stock Rating
Sell
36
Unicycive Therapeutics, Inc. (UNCY)
is a Sell
Is Unicycive Therapeutics, Inc. overpriced?
-
Unicycive Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Unicycive Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unicycive.com
52-Week Data
52-Week High:
11.00
52-Week Low:
3.71
Prediction Charts
Market Cap:
119.5M
Price in USD:
5.56
Volume:
390.1K
Beta:
1.87
Technical Analysis
SMA50:
5.37
SMA100:
4.80
SMA200:
5.33
52-Wk Change:
-21.69%
Stock Predictions
-
Is Unicycive Therapeutics, Inc. stock public?Yes, Unicycive Therapeutics, Inc. is a publicly traded company.
-
What is the Unicycive Therapeutics, Inc. stock quote today?The Unicycive Therapeutics, Inc. stock price is 5.56 USD today.
-
How to buy Unicycive Therapeutics, Inc. stock online?You can buy Unicycive Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 6.06 | 5.86 | 6.26 | 5.77 |
| Dec-3 | 5.91 | 6.17 | 6.22 | 5.91 |
| Dec-4 | 6.23 | 6.50 | 6.56 | 6.14 |
| Dec-5 | 6.57 | 6.23 | 6.60 | 6.20 |
| Dec-8 | 6.28 | 6.58 | 6.65 | 6.06 |
| Dec-9 | 6.54 | 6.52 | 6.95 | 6.48 |
| Dec-10 | 6.55 | 6.59 | 6.69 | 6.31 |
| Dec-11 | 6.59 | 6.41 | 6.63 | 6.32 |
| Dec-12 | 6.41 | 6.23 | 6.57 | 6.20 |
| Dec-15 | 6.31 | 5.88 | 6.31 | 5.86 |
| Dec-16 | 5.89 | 5.88 | 6.05 | 5.85 |
| Dec-17 | 5.88 | 5.45 | 5.91 | 5.42 |
| Dec-18 | 5.48 | 5.40 | 5.65 | 5.35 |
| Dec-19 | 5.45 | 5.56 | 5.58 | 5.37 |
Unicycive Therapeutics, Inc. Earnings
Unicycive Therapeutics, Inc. Earnings Report: Per Share Unicycive Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Unicycive Therapeutics, Inc. Forecast Revenue Growth
Unicycive Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Unicycive Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.02 per share, and an increase next year of $6.99 per share.
* Unicycive Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.